BYL719 : Addition of the p110α inhibitor BYL719 overcomes targeted therapy resistance in cells from Her2-positive-PTEN-loss breast cancer
IDN-6556: Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension
| Ganetespib : Inhibition of heat shock protein 90 exerts an antitumour effect in angiosarcoma: involvement of the vascular endothelial growth factor signalling pathwayIdasanutlin : Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53-Mutated Cells
|
Sulfopin : Discovery of potent PROTAC degraders of Pin1 for the treatment of acute myeloid leukemia
|
|
